SCHEMBL6011256

SCHEMBL6011256

Cc1ccc(-c2ccc(N)cc2N)c(O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
ALOX15 P16050 3/20 0.52
HSD17B10 Q99714 3/20 0.52
CASP1 P29466 3/20 0.47
TSHR P16473 2/20 0.47
PDE10A Q9Y233 1/20 0.47
TRPA1 O75762 2/20 0.46
TDP1 Q9NUW8 3/20 0.41
TP53 P04637 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP3A4 P08684 2/20 0.41
THRB P10828 1/20 0.41
ACHE P22303 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
CASP7 P55210 1/20 0.40
LMNA P02545 2/20 0.39
CHRM1 P11229 1/20 0.39
SLC6A2 P23975 1/20 0.39
ADRA1A P35348 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14293295 0.90 ALDH1A1 (0.64) ALDH1A1ALOX15HSD17B10TRPA1TDP1
SCHEMBL6011303 0.89 ALDH1A1 (0.53) ALDH1A1ALOX15HSD17B10CASP1TSHR
SCHEMBL6011538 0.87 CYP3A4 (0.54) ALDH1A1ALOX15HSD17B10CASP1TSHR
SCHEMBL5685322 0.85 CASP1 (0.50) ALDH1A1ALOX15HSD17B10CASP1TSHR
SCHEMBL6029171 0.85 ALDH1A1 (0.59) ALDH1A1ALOX15HSD17B10CASP1TSHR
SCHEMBL6574549 0.84 PDE10A (0.57) ALDH1A1ALOX15HSD17B10CASP1TSHR
SCHEMBL6011294 0.82 SMN1; SMN2 (0.48) ALDH1A1ALOX15HSD17B10CASP1TSHR
SCHEMBL6011361 0.82 CASP1 (0.52) ALDH1A1ALOX15HSD17B10CASP1TSHR
SCHEMBL5684835 0.80 CASP1 (0.57) ALDH1A1ALOX15HSD17B10CASP1TSHR
Hydrochloric Acid SCHEMBL6011598 0.80 CASP1 (0.50) ALDH1A1ALOX15HSD17B10CASP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1355619-B1 COLOURING AGENTS FOR KERATIN FIBRES CONTAINING (1.1'-BIPHENYL)-2.4-DIAMINE DERIVATIVES IN ADDITION TO NOVEL (1.1'-BIPHENYL)-2.4-DIAMINE-DERIVATIVES WELLA AG (DE) 2006-12-06 EP claimed
EP-1355619-B1 COLOURING AGENTS FOR KERATIN FIBRES CONTAINING (1.1'-BIPHENYL)-2.4-DIAMINE DERIVATIVES IN ADDITION TO NOVEL (1.1'-BIPHENYL)-2.4-DIAMINE-DERIVATIVES WELLA AG (DE) 2006-12-06 EP disclosed
US-7056347-B2 Coloring agents for keratin fibers containing (1,1′-biphenyl)-2,4-diamine derivatives in addition to novel (1,1′-biphenyl)-2,4-diamine-derivatives WELLA AG (DE) 2006-06-06 US disclosed
EP-1355619-A1 COLOURING AGENTS FOR KERATIN FIBRES CONTAINING (1.1'-BIPHENYL)-2.4-DIAMINE DERIVATIVES IN ADDITION TO NOVEL (1.1'-BIPHENYL)-2.4-DIAMINE-DERIVATIVES Wella Aktiengesellschaft (DE) 2003-10-29 EP disclosed
US-20030172470-A1 Colouring agents for keratin fibres containing (1.1'-biphenyl)-2.4-diamine derivatives in addition to novel (1.1'-biphenyl)-2.4-diamine-derivatives HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2003-09-18 US disclosed
WO-2002062307-A1 COLOURING AGENTS FOR KERATIN FIBRES CONTAINING (1.1'-BIPHENYL)-2.4-DIAMINE DERIVATIVES IN ADDITION TO NOVEL (1.1'-BIPHENYL)-2.4-DIAMINE-DERIVATIVES WELLA AKTIENGESELLSCHAFT (DE) 2002-08-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030172470-A1 Colouring agents for keratin fibres containing (1.1'-biphenyl)-2.4-diamine derivatives in addition to novel (1.1'-biphenyl)-2.4-diamine-derivatives KRT18, DSP, DSG1 ALDH1A1 120/4885ALOX15 4794/4885HSD17B10 3382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.